The short version is no, not by signing up directly — and the same is true of PayPal, Square, and Shopify Payments. Here is exactly what each platform’s policy says, why the account opens anyway, what happens to your money when it closes, and what the working alternatives actually are.
No — not by opening a Stripe account and plugging it into your peptide store. Stripe’s Restricted Businesses policy covers unapproved pharmaceuticals, nutraceuticals, and research chemicals, and research peptides sit inside it. Because Stripe boards merchants automatically with no underwriting, the account will open and process normally for a while — then close at the first review, typically with the balance held for 90–180 days. Shopify Payments is Stripe white-labelled, so it carries the same restriction. What does work is a payment relationship where the business is assessed up front rather than retroactively.
Worth reading precisely, because the wording is broader than most operators assume.
Stripe publishes a Restricted Businesses list that forms part of its Services Agreement. The relevant categories for this vertical are pseudo-pharmaceuticals and unapproved supplements, products making unsubstantiated health claims, and research chemicals. Research peptides are caught by these regardless of how the store labels them, and a “research use only” disclaimer does not move a product outside the list.
The critical thing to understand is when the policy is applied. Stripe is an aggregator: it boards merchants instantly and automatically, with no human underwriting, which is precisely what makes signup take ten minutes. Nothing checks what you sell at the moment you sign up. The policy is enforced later, when something triggers a review — a volume threshold, a dispute pattern, a routine site crawl, a customer complaint, or a bank enquiry.
That delay is why so many operators believe it works. Processing runs cleanly for weeks or months, right up until the first review, and the account that felt established is closed in a single email. The same structure and the same outcome apply at PayPal, Square, and Shopify Payments.
The store platform and the payment processor are two different decisions, and confusing them is the most common and most expensive mistake in this category.
| Platform | Who actually processes | Status | Why |
|---|---|---|---|
| Stripe (direct) | Stripe | Blocked | Research peptides fall under the Restricted Businesses policy. Signup is unreviewed, so the account opens — and closes at the first real review. |
| Shopify Payments | Stripe, white-labelled | Blocked | Shopify Payments is Stripe underneath, so the same restriction applies, and Shopify’s own Acceptable Use Policy limits the category on top of it. |
| PayPal / Braintree | PayPal | Blocked | Prohibited under the Acceptable Use Policy. PayPal is the most aggressive on holds, commonly 180 days. |
| Square | Square | Blocked | Prohibited. Square tends to freeze at the first chargeback rather than at review. |
| Cash App / Venmo | Block / PayPal | Blocked | Consumer rails, not merchant accounts. Using them for business sales breaches their terms and forfeits any dispute protection. |
| WooCommerce | Whatever you connect | Fine | Self-hosted and processor-agnostic. WooCommerce takes no position on what you sell, which is why most RUO operators end up here. |
| BigCommerce / Magento | Whatever you connect | Fine | Also processor-agnostic. The platform is never the blocker — the payment relationship behind it is. |
The pattern in that table is the whole lesson. Platforms that bundle their own payments — Shopify and Square — inherit the restrictions of the processor behind them, and Shopify Payments being Stripe underneath is the single most common surprise for peptide sellers. Platforms that stay out of the payment relationship — WooCommerce, BigCommerce, Magento — let you bring a processor that has actually agreed to serve you. That is why WooCommerce dominates this vertical: not because it is a better storefront, but because it does not decide who processes your cards.
The first week determines how much of your money you get back and whether this becomes a five-year problem. Most of the damage people take here is self-inflicted and avoidable.
Take the checkout offline rather than letting orders keep failing. Every additional charge attempted after a freeze adds to the balance being held and to the dispute count that follows.
The closure email usually cites a policy section or a reason code. That wording determines everything downstream: a restricted-business closure is very different from an excessive-chargeback termination, and only the latter puts you on MATCH.
Pull your full transaction history, payout reports, customer list, and dispute records now. Access is often restricted within days, and this history is the single strongest asset in your next underwriting application.
The held balance is released faster, and disputes stay lower, when customers receive what they paid for. Unfulfilled orders convert into chargebacks that count against you even after the account is closed.
Ask the acquirer directly whether you were placed on MATCH and under which reason code. You have a right to know, and if the listing is wrong, contesting it early is far easier than after five years have started running.
Do not open another aggregator account under a new name or entity. That is the fastest route to a second termination and a MATCH listing, and acquirers do check. Apply somewhere that will actually assess the business up front.
The one thing not to do: reopen under a new business name, a new entity, or a relative’s details. Acquirers share termination data, that behaviour is what MATCH reason code 08 exists to catch, and a listing lasts five years and follows you to every acquirer in the network.
Every route that lasts has one thing in common: someone assessed the business before it started processing, rather than after.
A real acquirer underwrites you and issues your own MID. It works and it lasts, but expect 8–15% all-in, a 5–10% reserve held 90–180 days, one to four weeks of underwriting, and often a $100,000 monthly minimum.
No card risk at all, and no chargebacks. The cost is conversion: most customers will not complete a purchase this way, and operators who switch typically report losing the majority of card-paying demand.
Brokkrpay screens the business up front, de-risks each transaction, and runs the payment on your own Stripe account, for a flat 2.5% plus Stripe’s standard rate. No reserve, and funds settle to your own balance.
A full cost breakdown, the underwriting checklist, and the chargeback thresholds that apply either way are on the peptide payment processing guide.
If Stripe identifies the category, yes. Research peptides fall under Stripe’s Restricted Businesses policy, and because Stripe boards merchants automatically with no underwriting, the account opens and processes normally until something triggers a review — a volume threshold, a dispute pattern, a site crawl, or a customer complaint. Closure usually comes with the balance held for the dispute window, commonly 90–180 days.
You can host a peptide store on Shopify, but you generally cannot use Shopify Payments for it, because Shopify Payments is Stripe white-labelled and inherits Stripe’s restrictions. Shopify’s own Acceptable Use Policy also limits how these products may be sold. Shopify does let you connect an approved third-party gateway instead, which is the route peptide sellers on Shopify have to take.
For payments, yes, and that is usually the deciding factor. WooCommerce is self-hosted and processor-agnostic — it takes no position on what you sell and does not bundle its own payments — so you can connect whichever processor has agreed to serve you. Shopify pushes hard toward Shopify Payments, which is Stripe. Most research peptide operators end up on WooCommerce for this reason rather than for any storefront advantage.
Typically 90 to 180 days. The hold covers the window in which cardholders can still raise disputes on charges you already took, so the balance is retained until that exposure passes. Fulfilling every paid order is the most effective thing you can do to shorten it and to keep disputes from accumulating against the held balance.
You should not try. Stripe links accounts by entity, beneficial owner, bank account, domain, and device signals, and a replacement account is normally closed quickly. More seriously, deliberately evading a termination is what Mastercard’s MATCH reason code 08 (Questionable Merchant Audit Program) exists to capture, and a MATCH listing lasts five years and follows you to every acquirer in the network.
In the United States, selling peptides labelled and marketed strictly for laboratory research use is generally lawful, but it is tightly bounded. The products cannot be marketed for human consumption, and no therapeutic, dosing, or health claims may appear anywhere in your marketing. Marketing them for human use moves them into unapproved-new-drug territory and attracts FDA enforcement. Rules differ by country, and this is not legal advice — take advice specific to your jurisdiction and product range.
No. PayPal and Square both prohibit the category in their acceptable use policies, and PayPal is the most aggressive on holds, commonly 180 days. Venmo and Cash App are consumer payment rails, not merchant accounts: using them for business sales breaches their terms, gives you no chargeback protection, and creates a bookkeeping and tax problem on top.
A dedicated high-risk merchant account is the traditional route and typically costs 8–15% all-in with a 5–10% rolling reserve. Crypto and bank transfer cost almost nothing but lose most card-paying customers at checkout. Brokkrpay sits between the two: a flat 2.5% plus Stripe’s standard rate, processed on your own Stripe account with no reserve, which works out to roughly a third of typical high-risk pricing.
Tell us your vertical and your monthly volume. Approved operators are live on their own Stripe account within a day.